PTK2, protein tyrosine kinase 2, 5747

N. diseases: 205; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 PosttranslationalModification disease BEFREE Accordingly, increased FAK tyrosine phosphorylation was observed within HGSOC patient tumors surviving neo-adjuvant chemotherapy. 31478830 2019
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 Biomarker disease BEFREE Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer. 29743815 2018
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 PosttranslationalModification disease BEFREE Finally, we showed that digitoxin inhibited FAK phosphorylation in SKOV3 but not PYK2 phosphorylation in monocytes, thus providing a molecular mechanism accounting for the observed differential anti-migratory effect. 29890142 2018
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 PosttranslationalModification disease BEFREE Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer. 28990249 2017
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 Biomarker disease BEFREE Frequent Loss of NISCH Promotes Tumor Proliferation and Invasion in Ovarian Cancer via Inhibiting the FAK Signal Pathway. 25724667 2015
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 Biomarker disease BEFREE Focal adhesion kinase (FAK) is a cytoplasmic protein-tyrosine kinase located on chromosome 8q24.3 (gene is Ptk2), a site commonly amplified in serous ovarian cancer. 23275034 2013
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 Biomarker disease BEFREE Dual targeting of EphA2 and FAK may have therapeutic implications for ovarian cancer management. 19395869 2009
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 AlteredExpression disease LHGDN Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells. 18353772 2008
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 Biomarker disease LHGDN Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer. 18632638 2008
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.100 AlteredExpression disease LHGDN Taken together, our results demonstrated for the first time FHL2 expression in human ovarian cancer cells, suggesting an important functional role of pp125FAK and FHL2 complex in gynecologic malignancies. 15161045 2004